RECOVERY / SINGLE
LL37
5MGThis content is intended for educational and research reference only and does not constitute medical advice, diagnosis, or treatment. Experimental compounds are for research use only and are not for human consumption. Always consult qualified healthcare providers before starting any therapy.
Research Overview
A cationic antimicrobial peptide studied for its role in innate-immune and wound-healing research.
Available Strengths
- 5MG (375)
Research Protocol
Reference 8-week titration
| Period | Dose | U-100 units | Volume |
|---|---|---|---|
| Week 1 | 0.05 mg | 3 | 0.03 mL |
| Week 2 | 0.1 mg | 6 | 0.06 mL |
| Week 3 | 0.15 mg | 9 | 0.09 mL |
| Week 4 | 0.2 mg | 12 | 0.12 mL |
| Week 5 | 0.25 mg | 15 | 0.15 mL |
| Week 6 | 0.3 mg | 18 | 0.18 mL |
| Week 7 | 0.35 mg | 21 | 0.21 mL |
| Week 8 | 0.4 mg | 24 | 0.24 mL |
Reconstitution
≈1.67 mg/mL once reconstituted
- Draw 3.0 mL of bacteriostatic water per 5 mg vial.
- Inject slowly along the vial wall; swirl gently until dissolved.
Research context
Discussed as disrupting microbial membranes through its cationic alpha-helical structure, and as modulating immune responses by inducing neutrophil microvesicle release and blocking LPS-TLR4 interaction in the cited research.
Storage
−20°C, cited as stable around 24 months. 2–8°C for 4 weeks, or −20°C for up to 6 months; avoid repeated freeze-thaw cycles.
Research Notes
- For educational and research reference only. Not medical advice and not intended for unsupervised human use.
References
Source reference: PeptideDosages.com · 2026-08-18 · Exact strength match with the cited source